The emerging role of circular RNAs in acute and chronic heart failure: mechanisms, biomarkers, and therapeutic potential

Abstract

Circular RNAs (circRNAs) are covalently closed non-coding RNAs with diverse regulatory functions, high stability, and tissue specificity. This review examines their biogenesis, molecular mechanisms, experimental evidence, biomarker potential, and therapeutic implications in acute heart failure and chronic heart failure. By functioning as microRNA sponges, interacting with RNA-binding proteins, acting as protein scaffolds, undergoing cap-independent translation, and participating in stress-response signaling, circRNAs may regulate heart failure progression. Representative circRNAs, including circHIPK3, circSIRT1, circSLC8A1, circRNA-00203, and HRCR, have been linked to cardiomyocyte injury, calcium homeostasis, apoptosis, hypertrophy, fibrosis, inflammation, and ventricular remodeling. Circulating and exosome-derived circRNAs may also serve as biomarkers for diagnosis, prognosis, and disease monitoring. However, clinical translation remains limited by challenges in detection and standardization, low transcript abundance, tissue and cell heterogeneity, delivery efficiency, off-target effects, immunogenicity, and insufficient validation in large clinical cohorts. Most available evidence comes from preclinical models of myocardial infarction, pressure overload, and cardiac remodeling; evidence in heart failure with preserved ejection fraction , heart failure with mildly reduced ejection fraction, and large human populations remains limited. Overall, circRNAs provide new insights into heart failure pathophysiology and represent promising candidates for biomarker development and targeted therapy, but rigorous clinical validation is required before routine application.

Keywords

circRNA / back-splice junction / miRNA sponges / heart failure / myocardial hypertrophy / cardiac remodeling / therapeutic targets

References

[1] Zhang X,Zhang Y,Chen L.Complementary sequence-mediated exon circularization.Cell2014;159:134-47

[2] Conn SJ,Toubia J.The RNA binding protein quaking regulates formation of circRNAs.Cell2015;160:1125-34

[3] Jeck WR,Wang K.Circular RNAs are abundant, conserved, and associated with ALU repeats.RNA2013;19:141-57 PMCID:PMC3543092

[4] Tan WL,Anene-nzelu CG.A landscape of circular RNA expression in the human heart.Cardiovasc Res2017;cvw250

[5] Mcdonagh TA,Adamo M.2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur Heart J2021;42:3599-726

[6] Heidenreich PA,Aguilar D.2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines.Circulation2022;145

[7] Savarese G,Lund LH,Rosano GMC.Global burden of heart failure: a comprehensive and updated review of epidemiology.Cardiovasc Res2022;118:3272-87

[8] Hao G,Chen Z.Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012-2015.Eur J Heart Fail2019;21:1329-37

[9] An D,Zhang P.Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice.Redox Biol2021;46:102088 PMCID:PMC8353361

[10] Tran DH,Li Q.Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling.Nat Commun2020;11:1771 PMCID:PMC7156663

[11] Zhai C,Wu H.Knockdown of circ_0060745 alleviates acute myocardial infarction by suppressing NF‐κB activation.J Cell Mol Med2020;24:12401-10 PMCID:PMC7687010

[12] Gao X,Zhang Y.The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression.Cell Death Differ2021;29:527-39 PMCID:PMC8901615

[13] Madè A,Garcia-manteiga JM.circRNA-miRNA-mRNA deregulated network in ischemic heart failure patients.Cells2023;12:2578 PMCID:PMC10648415

[14] Neufeldt D,Mohr E.Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival.Basic Res Cardiol2024;119:613-32 PMCID:PMC11319402

[15] Acharya P,Tranter M.RNA binding proteins as mediators of pathological cardiac remodeling.Front Cell Dev Biol2024;12:1368097 PMCID:PMC11137256

[16] Garikipati VNS,Cheng Z.Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis.Nat Commun2019;10:4317 PMCID:PMC6754461

[17] Bian Y,Li X.CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.J Mol Cell Cardiol2021;158:128-39

[18] Wang J,Rockman HA.G-protein-coupled receptors in heart disease.Circ Res2018;123:716-35 PMCID:PMC6205195

[19] Shen Z,Liu W,Yuan L.Prediction of back-splicing sites for circRNA formation based on convolutional neural networks.BMC Genom2022;23:581 PMCID:PMC9373444

[20] Greene J,Brady L.cirRNA: biogenesis, function and role in human diseases.Front Mol Biosci2017;4:38 PMCID:PMC5459888

[21] Kirio K,Anduaga AM.cirRNA exhibit exceptional stability in the aging brain and serve as reliable age and experience indicators.Cell Rep2025;44:115485 PMCID:PMC12105716

[22] Hwang HJ.Molecular mechanisms of circular RNA translation.Exp Mol Med2024;56:1272-80 PMCID:PMC11263353

[23] Ren L,Mo L.Mechanisms of circular RNA degradation.Commun Biol2022;5:1355 PMCID:PMC9734648

[24] Kristensen LS,Stagsted LVW,Hansen TB.The biogenesis, biology and characterization of cirRNA.Nat Rev Genet2019;20:675-91

[25] Zhang L,Yu F,Gao H.The circRNA-miRNA/RBP regulatory network in myocardial infarction.Front Pharmacol2022;13:941123 PMCID:PMC9340152

[26] Li Y,Bao C.Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.Cell Res2015;25:981-4 PMCID:PMC4528056

[27] Huang C,Tatomer DC.A length-dependent evolutionarily conserved pathway controls nuclear export of cirRNA.Genes Dev2018;32:639-44 PMCID:PMC6004072

[28] Mahmoudi E.cirRNA are temporospatially regulated throughout development and ageing in the rat.Sci Rep2019;9:2564 PMCID:PMC6385508

[29] Bibi A,Gandhi S.Circular RNA regulatory role in pathological cardiac remodelling.Br J Pharmacol2024;182:316-39

[30] Cheng Y,Wang S.Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia.Genes2020;11:868 PMCID:PMC7465400

[31] Ma C,Wang X.circRNA CDR1as promotes pulmonary artery smooth muscle cell calcification by upregulating CAMK2D and CNN3 via sponging miR-7-5p.Mol Ther Nucl Acids2020;22:530-41 PMCID:PMC7566008

[32] Zhang N,Li Y.Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer.Commun Biol2025;8:77 PMCID:PMC11748638

[33] Zang Y,Wan B.circRNA circ‐CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR‐646.J Cell Mol Med2020;24:2423-33 PMCID:PMC7028846

[34] Legnini I,Rossi F.Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis.Mol Cell2017;66:22-37.e9 PMCID:PMC5387670

[35] Zhou C,Daneshvar K.Genome-wide maps of m⁶A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs.Cell Rep2017;20:2262-76 PMCID:PMC5705222

[36] Payea MJ,Malla S.Ribonucleic acid-mediated control of protein translation under stress.Antioxid Redox Signal2023;39:374-89 PMCID:PMC10443204

[37] Zhang J,Zhang H.Decoding circRNA translation: challenges and advances in computational method development.Front Genet2025;16:1654305 PMCID:PMC12339343

[38] Shan T,Jing P.Circular RNA IGF1R promotes cardiac repair via activating β-catenin signaling by interacting with DDX5 in mice after ischemic insults.Research2024;7:0451 PMCID:PMC11347128

[39] Arrigo M,Mullens W.Acute heart failure.Nat Rev Dis Primers2020;6:16 PMCID:PMC7714436

[40] Deng Y,Xie G,Li H.Circ-HIPK3 strengthens the effects of adrenaline in heart failure by MiR-17-3p - ADCY6 axis.Int J Biol Sci2019;15:2484-96 PMCID:PMC6775314

[41] Zhang L,Yu F,Gao H.CircHIPK3 plays vital roles in cardiovascular disease.Front Cardiovasc Med2021;8:733248 PMCID:PMC8511503

[42] Xu X,Wang X.Silencing of circHIPK3 inhibits pressure overload-induced cardiac hypertrophy and dysfunction by sponging miR-185-3p.Drug Des Devel Ther2020;14:5699-710 PMCID:PMC7778681

[43] Wang W,Yang M.Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy.Cell Death Dis2021;12:1069 PMCID:PMC8580993

[44] Metra M.Heart failure.Lancet2017;390:1981-95

[45] Lim TB,Luu TDA.Targeting the highly abundant circular RNA circSLC8A1 in cardiomyocytes attenuates pressure overload induced hypertrophy.Cardiovasc Res2019;115:1998-2007

[46] Yang T,Du T,Dong Y.Circle the cardiac remodeling with circRNAs.Front Cardiovasc Med2021;8:702586 PMCID:PMC8267062

[47] Li M,Tariq MA.A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p.Theranostics2018;8:5855-69 PMCID:PMC6299442

[48] Li H,Fang X.Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.Cardiovasc Res2020;116:1323-34 PMCID:PMC7243276

[49] Wang K,Liu F.A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.Eur Heart J2016;37:2602-11

[50] Yuan Z,Jin X.cirRNA in cardiovascular diseases: molecular mechanisms, therapeutic advances, and innovations.Genes2024;15:1423 PMCID:PMC11593509

[51] Capirossi G,Tremoli E,Roncarati R.cirRNA in cardiovascular physiopathology: from molecular mechanisms to therapeutic opportunities.Int J Mol Sci2025;26:9725 PMCID:PMC12525237

[52] Zhang J.Circular RNA discovery with emerging sequencing and deep learning technologies.Nat Genet2025;57:1089-102

[53] Nielsen AF,Bozzoni I.Best practice standards for circular RNA research.Nat Methods2022;19:1208-20 PMCID:PMC9759028

[54] Szabo L.Detecting circular RNAs: bioinformatic and experimental challenges.Nat Rev Genet2016;17:679-92 PMCID:PMC5565156

[55] Siede D,Gorska A.Identification of cirRNA with host gene-independent expression in human model systems for cardiac differentiation and disease.J Mol Cell Cardiol2017;109:48-56

[56] Hatzimanolis O,Cristino AS.cirRNA in neurological conditions - computational identification, functional validation, and potential clinical applications.Mol Psychiatry2025;30:1652-75 PMCID:PMC11919710

[57] Wen N,Xiong X.Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring.Sig Transduct Target Ther2024;9:107 PMCID:PMC11636852

[58] Dong J,Huang Y,Cheng Z.Challenges and opportunities for circRNA identification and delivery.Crit Rev Biochem Mol Biol2023;58:19-35

[59] Young T, Chang Wang K, James Varley A, Li B. Clinical delivery of circular RNA: lessons learned from RNA drug development.Adv Drug Delivery Rev2023;197:114826

[60] Cao X,Zhang J.Engineering circular RNA medicines.Nat Rev Bioeng2024;3:270-87

[61] You Q,Pan R,Guo H.Decoding the regulatory roles of circular RNAs in cardiac fibrosis.Non-coding RNA Res2025;11:115-30 PMCID:PMC11697406

[62] Bo X,Chen S.Evidence and perspectives on miRNA, circRNA, and lncRNA in myocardial ischemia-reperfusion injury: a bibliometric study.J Cardiothorac Surg2025;20:66 PMCID:PMC11736979

[63] Pan R,Su W,Guo H.cirRNA modulate cell death in cardiovascular diseases.Cell Death Discov2025;11:214 PMCID:PMC12048724